Research progress of human derived xenograft models in primary liver cancer / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
; (12): 868-871, 2021.
Article
en Zh
| WPRIM
| ID: wpr-910651
Biblioteca responsable:
WPRO
ABSTRACT
With the development and marketing of a variety of new anti-tumor drugs, it the patients with liver cancer were benefited but it also raised a series of new problems. How to develop individualized therapeutic plans for the patients with liver cancer has always been bothering the clinicians. Patient-derived xenograft model retains the histological characteristics, molecular diversity and microenficity of human-derived tumors, and it can help conduct in vitro experiments, which can solve the above problems to a certain extent. This article summarizes the research progress of the application of patient-derived xenograft models on the diagnosis and treatment of primary liver cancer.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Hepatobiliary Surgery
Año:
2021
Tipo del documento:
Article